Elevated creatine kinase does not necessarily correspond temporally with onset of muscle rigidity in neuroleptic malignant syndrome: a report of two cases
Koichi NisijimaDepartment of Psychiatry, Jichi Medical University, Tochigi, JapanAbstract: Neuroleptic malignant syndrome is an uncommon but dangerous complication of antipsychotic drugs, characterized by clinical symptoms that include hyperthermia, severe muscle rigidity, autonomic dysfunction, and...
Guardado en:
Autor principal: | Nisijima K |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c14351c7f0994c65b886652917c0f4ab |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Temporal changes in serum creatine kinase concentration and degree of muscle rigidity in 24 patients with neuroleptic malignant syndrome
por: Nisijima K, et al.
Publicado: (2013) -
Neuroleptic malignant syndrome: an easily overlooked neurologic emergency
por: Oruch R, et al.
Publicado: (2017) -
Neuroleptic malignant syndrome and subsequent clozapine-withdrawal effects in a patient with refractory schizophrenia
por: Cheng MF, et al.
Publicado: (2016) -
Role of Creatine Kinase in the Troponin Era: A Systematic Review
por: Daniel Beamish, et al.
Publicado: (2021) -
Ropivacaine: An Unusual Cause of Neuroleptic Malignant-Like Syndrome
por: Miguel Santos, et al.
Publicado: (2021)